Meet Galapagos and its founder Onno van de Stolpe

You have examined the claims of the patent that protects the compound filgotinib of the publicly-traded company Galapagos. In the video interview below, you will meet the founder and CEO of Galapagos, Onno van de Stolpe. He will briefly explain how his company started, and how important patents are for a biotech company like Galapagos.